3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
64
Neoplasm Metastasis
14
Brain Neoplasms
10
Neoplasms
9
Endometrial Neoplasms
8
Prostatic Neoplasms
7
Glioblastoma
7
Ovarian Neoplasms
6
Triple Negative Breast Neoplasms
5
Glioma
5
Sarcoma
3
Recurrence
3
Neoplasms by Site
3
Meningioma
3
Carcinoma, Non-Small-Cell Lung
3
Breast Diseases
3
Unilateral Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma, Ewing
2
Osteosarcoma
2
Liposarcoma
2
Head and Neck Neoplasms
2
Fallopian Tube Neoplasms
2
Ependymoma
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Renal Cell
2
Advanced Breast Cancer
2
Uterine Cervical Neoplasms
1
Urogenital Neoplasms
1
Interventions
venetoclax
69
Cyclophosphamide
53
ibrutinib
44
obinutuzumab
43
acalabrutinib
42
Rituximab
40
fludarabine
37
fludarabine phosphate
30
Specimen Handling
29
pirtobrutinib
25
Biopsy
24
zanubrutinib
23
Whole-Body Irradiation
16
Bendamustine Hydrochloride
15
Magnetic Resonance Spectroscopy
14
Mycophenolic Acid
13
Lenalidomide
11
Peripheral Blood Stem Cell Transplantation
9
Sirolimus
8
idelalisib
7
Tacrolimus
7
CT-P10
7
ARQ531
7
tafasitamab
6
Prednisone
6
Busulfan
6
pembrolizumab
5
Stem Cell Transplantation
5
Melphalan
5
Interleukin-2
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Lymphocytic, Chronic, B-Cell
×
abemaciclib
×
1 year
×
Clear all
No trials found.